This is the sixth story in Cancer Capitalism, a series about how the hunt for profit can harm cancer patients. You can read the first story
This is the sixth story in Cancer Capitalism, a series about how the hunt for profit can harm cancer patients. You can read the first story here.
Jacqueline Trapp was paying down her mortgage and looking forward to early retirement when she got multiple myeloma a decade ago at the age of 50. She’s kept her disease mostly under control since then with a drug that lists for over $800 per pill, taken 21 ...